IDEAYA Biosciences announced that Stu Dorman is joining the company as its chief commercial officer. 1 The precision medicine oncology company is preparing to shift to becoming a commercial launch ...

Ideaya (IDYA) announced the appointment of Stu Dorman as chief commercial officer ... U.S. oncology business unit head at Gilead Science (GILD).

Dorman. Prior to joining IDEAYA, Mr. Dorman was the Vice President, U.S. Oncology Business Unit Head at Gilead Sciences, where he successfully built a leading oncology commercial organization with ...

Ideaya (IDYA) announced the appointment of Stu Dorman as chief commercial officer ... U.S. oncology business unit head at Gilead Science (GILD). Don't Miss our Black Friday Offers: Published ...

Morningstar brands and products Company Portfolio ...